- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Epothilones
Total 84 results
-
R-PharmUS Oncology ResearchCompletedMetastatic Breast CancerUnited States
-
Hellenic Cooperative Oncology GroupTerminatedMetastatic Breast CancerGreece
-
BayerCompletedBreast NeoplasmUnited States, Canada
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticFrance, Germany, Spain, Austria, Belgium, Slovenia, Poland, Bulgaria, United Kingdom, Italy
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung Cancer | Brain MetastasisUnited States
-
R-PharmCompleted
-
BayerCompletedCarcinoma, Non Small Cell LungGermany
-
National Cancer Institute (NCI)TerminatedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Carcinoma | Cervical Carcinoma, Non-SquamousTypeUnited States
-
University of ZurichCompletedRecurrent Glioblastoma Planned for Reoperation
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedAdvanced MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
Novartis PharmaceuticalsCompletedSolid Tumors | Advanced MalignanciesUnited States
-
British Columbia Cancer AgencyCompletedHormone Refractory Prostate CancerCanada
-
SCRI Development Innovations, LLCBristol-Myers Squibb; BayerCompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan, Korea, Republic of
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Sarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
R-PharmCompletedMetastatic Breast Cancer | Triple Negative Locally Advanced Non-resectable Breast CancerCzech Republic, Italy, Poland, Spain, Austria, France, Greece
-
Novartis PharmaceuticalsCompletedColon CancerSpain, United Kingdom, France, Czechia
-
H. Lee Moffitt Cancer Center and Research InstituteBayerCompleted
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
R-PharmCompletedNon-small Cell Lung Cancer (NSCLC)Japan
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
R-PharmTerminated
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
University of Southern CaliforniaNovartisUnknownColorectal Cancer | Colon CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Recurrent Uterine Corpus Cancer | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer... and other conditionsUnited States
-
R-PharmCompletedMetastatic Breast CancerItaly, United Kingdom, United States, France, Spain
-
R-PharmCompleted
-
BayerCompletedOvarian Cancer | Prostate CancerItaly, Belgium, Netherlands, France, Germany, United Kingdom